Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Life satisfaction, loneliness, and mental health in older adults: sociodemographic influences in a cross-sectional analysis.

BMC geriatrics·2026
Same author

Lipidomic Analysis of Human Plasma and Hippocampus Across Alzheimer's Progression and Preclinical 5xFAD Mouse Model.

Molecular neurobiology·2026
Same author

Validation of the Spanish version of the social and emotional loneliness scale for adults - short form (SELSA-S) in older adults.

BMC research notes·2026
Same author

Fat for thought: Lipid regulation of neural stem cell fate.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Correction: Apache is a neuronal player in autophagy required for retrograde axonal transport of autophagosomes.

Cellular and molecular life sciences : CMLS·2025
Same author

TBC1D24 interacts with the v-ATPase and regulates intraorganellar pH in neurons.

iScience·2025

相关实验视频

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

药物开发 药物开发

Enrico Castroflorio1,2, Joan Cabot1,2, Margalida Suau2

  • 1Laminar Pharmaceuticals S.A., Palma, Spain.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

基于脂质的化合物,docosahexaenoic酸衍生物 (DHA-H) 和其代谢物 (HPA),促进神经发生和神经元成熟. 这些发现表明,对于像阿尔茨海默氏症这样的神经退行性疾病,潜在的基于脂质的治疗方法.

更多相关视频

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

相关实验视频

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

科学领域:

  • 神经科学是一个神经科学.
  • 利皮多米克 (Lipidomics) 是一种消化剂.
  • 神经退行性疾病 神经退行性疾病

背景情况:

  • 脂质对神经元功能至关重要,它们的不平衡有助于像阿尔茨海默氏症这样的神经退行性疾病.
  • 对神经系统疾病的基于脂质的干预措施的治疗潜力在很大程度上尚未被探索.

研究的目的:

  • 为了研究氧化多可萨赫萨酸衍生物 (DHA-H) 和其代谢物 (HPA) 对神经元增殖和分化的影响.
  • 探索阿尔茨海默病模型中的潜在机制和潜在的治疗应用.

主要方法:

  • 主要神经圈培养,免疫细胞化学,免疫光标记,共聚焦显微镜,西斑,和qPCR.
  • 使用5xFAD小鼠和野生类型 (WT) 小鼠进行体外和体内研究.
  • 分析神经元增殖和分化标志物,受体识别 (GPR37) 和信号通路变化 (MAPK,mTOR).

主要成果:

  • 在体外,DHA-H和HPA显著增强神经元增殖 (Ki-67,Sox2,Nestin,BrdU结合) 和分化 (双丁,NeuroD1,PSA-NCAM).
  • 在体内治疗促进了WT和5xFAD小鼠的牙状环中的神经元原生细胞增殖.
  • 观察到GPR37受体上调和MAPK和mTOR信号通路的改变,这表明了其主要的作用机制.

结论:

  • 基于脂质的化合物DHA-H和HPA表现出神经性和神经成熟作用.
  • 这些发现支持基于脂质的干预措施在神经退行性疾病中恢复神经发生的潜力.